Mir-629 Repressed LATS2 Expression and Promoted the Proliferation of Prostate Cancer Cells

Author:

Li Yuqiao1,Zeng Sha1,Cao Longbin1

Affiliation:

1. Department of Urology, Liaocheng People’s Hospital, Liaocheng City, China

Abstract

AbstractMicroRNAs (miRNAs) have been discovered to play critical role in regulating prostate cancer (PC) progression. The function role of miR-629 in tumor progression of PC has not been studied. Here, we found that miR-629 was markedly upregulated in PC as determined using the cancer genome atlas (TCGA) dataset, clinical tissues, and cell lines. Functional analysis (MTT assays, colony formation assays, soft agar growth assay and BrdU incorporation assay) indicated that overexpression of miR-629 was drastically promoted, while miR-629-in significantly suppressed cell proliferation. LATS2 was predicted as a direct target of miR-629 and was confirmed by western blot and dual luciferase assay. Through downregulation of large tumor suppressor 2 (LATS2) by overexpression of miR-629, the p21 mRNA and protein were decreased while the Cyclin D3 mRNA and protein were enhanced, suggesting promoting of cell proliferation process. Additionally, knockdown of LATS2 reversed the inhibitory effect by miR-629-in in PC. Our study indicated that miR-629 might serve as a new promising target for PC treatment.

Publisher

Georg Thieme Verlag KG

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,General Medicine,Endocrinology, Diabetes and Metabolism

Reference35 articles.

1. Cancer statistics, 2019;R L Siegel;Cancer J Clin,2019

2. CCAR1 5’ UTR as a natural miRancer of miR-1254 overrides tamoxifen resistance;G Li;Cell Res,2016

3. miR-634 exhibits anti-tumor activities toward hepatocellular carcinoma via Rab1A and DHX33;C Z Zhang;Mol Oncol,2016

4. Targeting of TLE3 by miR-3677 in human breast cancer promotes cell proliferation, migration and invasion;L-N Peng;Oncology Lett,2020

5. A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer;L A Selth;Oncogene,2017

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3